RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients

Background: Recently, markers related to molecular classification were suggested as promising therapeutic targets for treatment and prediction of prognosis in gastric cancer (GC), including c-MET, RhoA, and Claudin-18 (CLDN18). This study aimed to investigate their expression in GC and its correlati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Marina Alessandra, Ramos, Marcus Fernando Kodama Pertille, Dias, Andre Roncon, Cardili, Leonardo, Ribeiro, Renan Ribeiro e, de Castria, Tiago Biachi, Zilberstein, Bruno, Nahas, Sergio Carlos, Ribeiro, Ulysses, de Mello, Evandro Sobroza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788521/
https://www.ncbi.nlm.nih.gov/pubmed/35076580
http://dx.doi.org/10.3390/medsci10010004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788521/
https://www.ncbi.nlm.nih.gov/pubmed/35076580
http://dx.doi.org/10.3390/medsci10010004

Ejemplares similares